Automated Fluid Output Tracking Device for Monitoring Hospital Patients
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine whether a prototype toilet device that we have developed can accurately and automatically track human fluid output from renal and gastrointestinal systems in the hospital. The device includes components that can be outfitted onto existing toilets. In this study, participants hospital room will be outfitted with the prototype toilet device. Participants will use the toilet as usual throughout the duration of their inpatient stay. Sometimes output will be measured by the device, and other times output will be measured manually by nurses.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on monitoring fluid output, so it's unlikely that your medications will need to be changed, but please confirm with the trial coordinators.
What data supports the effectiveness of the treatment Automated Fluid Output Tracking Device for Monitoring Hospital Patients?
Research shows that smart toilet systems can effectively monitor health by analyzing urine and stool, similar to how the Automated Fluid Output Tracking Device might work. Additionally, automated systems like PleurAlert and other urine monitoring devices have been shown to reduce workload for healthcare staff and improve accuracy in monitoring fluid output, suggesting potential benefits for hospital patients.12345
Is the Automated Fluid Output Tracking Device safe for use in humans?
How does the automated fluid output tracking device differ from other treatments for monitoring hospital patients?
The automated fluid output tracking device is unique because it continuously and automatically measures urine output, reducing the workload on healthcare staff and minimizing human error. Unlike traditional methods that require manual measurement, this device uses advanced sensors and technology to provide real-time data and alerts, making it more efficient and reliable for monitoring patients in critical care.23101112
Research Team
Chenyu Lin, MD
Principal Investigator
Duke University
Eligibility Criteria
This trial is for English-reading adults aged 18-80 who are scheduled for a stem cell transplant at the Duke ABMT clinic and have a Karnofsky Performance Scale score of 70 or above. It's not suitable for those with physical constraints that prevent standard toilet use, such as waste excretion through stoma or catheter.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Inpatient Monitoring
Participants' hospital rooms are outfitted with the prototype toilet device to automatically track fluid output during their inpatient stay.
Follow-up
Participants are monitored for safety and effectiveness after the inpatient stay
Treatment Details
Interventions
- Electronic Device for Toilet
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor